Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2010
09/22/2010CN101838321A Fe(II) transportproteins of peanut nodule and coding genes thereof
09/22/2010CN101838320A Drying and desolventizing method of polar-solvent-containing protein feed
09/22/2010CN101838319A Asia 1-type FMDV compound multiepitope
09/22/2010CN101838318A Anti-HIV-I polypeptide and coding sequence and use thereof
09/22/2010CN101838317A Mimic short peptide 11B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838307A K2 polypeptide synthesis product and application thereof
09/22/2010CN101838306A K4 polypeptide synthesis product and application thereof
09/22/2010CN101838305A T2 peptide synthesis product and application thereof
09/22/2010CN101177454B IL-18 mutant polypeptide as well as preparation and usage
09/21/2010USRE41745 Vector; genetic vaccines for humans or horses; side effect reduction; increasing the protectiveness of a vaccinia-based vaccine
09/21/2010US7799905 T1R1 nucleic acid sequences and vectors containing same
09/21/2010US7799902 Receptor coupling agents and compositions thereof
09/21/2010US7799901 capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 (mediators of receptor toxicity) protein
09/21/2010US7799898 Human transferase family members and uses thereof
09/21/2010US7799896 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
09/21/2010US7799767 Cross-linked bioactive hydrogel matrices
09/21/2010US7799760 Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
09/21/2010US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
09/21/2010US7799758 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
09/21/2010US7799757 Treatment of osteoporosis, for the promotion of bone formation or for the inhibition of bone loss; genetic engineering; side effect reduction
09/21/2010US7799566 Cyclin D polynucleotides, polypeptides and uses thereof
09/21/2010US7799552 Vector for use as a tool in tranfer and express of preferential nucleotide sequences
09/21/2010US7799549 Methods for increasing protein polyethylene glycol (PEG) conjugation
09/21/2010US7799543 Human tumor necrosis factor receptor polynucleotides
09/21/2010US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction
09/21/2010US7799533 Polypeptides, their production and use
09/21/2010US7799529 Nephrin gene and protein
09/21/2010US7799528 determining whether a first population of human cells comprises CD34+CD38-Lin- hematopoietic stem cells isolated from normal human bone marrow, cord blood, and peripheral blood stem cell preparations
09/21/2010US7799518 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
09/21/2010US7799330 comprises claimed amino acid sequence or an immunogenic fragment thereof wherein the protein elicits production of antibodies that interfere with invasion by Babesia bovis into erythrocytes
09/21/2010US7799323 Using interleukin-31(IL-31) agonist for treatment and prevention of allergic rhinitis
09/21/2010CA2461846C Plant reproduction polynucleotides and methods of use
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2384880C Methods for making recombinant proteins using apoptosis inhibitors
09/21/2010CA2370493C Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
09/21/2010CA2370138C Polynucleotide probes for detection and quantitation of staphylococcus
09/21/2010CA2367457C Protein for blocking platelet adhesion
09/21/2010CA2330241C Attenuated pestiviruses
09/21/2010CA2327353C Structural proteins of fish pancreatic disease virus and uses thereof
09/21/2010CA2323756C Genetic engineering salt tolerance in crop plants
09/21/2010CA2309356C Novel exendin agonist compounds
09/21/2010CA2308791C Method to screen phage display libraries with different ligands
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/21/2010CA2294211C Method of increasing fruit size in a plant
09/21/2010CA2290614C Process for the preparation of polymers having nucleobases as side groups
09/21/2010CA2279550C Enhancement of growth in plants
09/21/2010CA2251655C In vivo gene transfer methods for wound healing
09/21/2010CA2234941C Delivery of biologically active polypeptides
09/21/2010CA2225788C Therapeutic agents and autoimmune diseases
09/21/2010CA2225675C Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
09/21/2010CA2192694C Cloning and expression of an acetylcholine-gated ion channel receptor subunit
09/21/2010CA2172145C Metal complexes with a charged linker
09/17/2010CA2658714A1 Hcv-derived polypeptides and uses thereof
09/16/2010WO2010105227A1 Methods of renaturation of recombinant proteins
09/16/2010WO2010105128A2 A pkn3/rhoc macromolecular complex and methods of use therefor
09/16/2010WO2010104821A1 Mirac proteins
09/16/2010WO2010104761A2 Anti-cd40 antibodies and uses thereof
09/16/2010WO2010104696A1 Method and composition for the treatment of moderate to severe keratoconjunctivitis sicca
09/16/2010WO2010104596A1 Fluorobodies: intrinsically fluorescent binding ligands
09/16/2010WO2010104357A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy
09/16/2010WO2010104124A1 Method for fluorescently labeling protein
09/16/2010WO2010104114A1 Method for preparing polypeptide library
09/16/2010WO2010103517A1 Soluble compositions for the treatment of cxcr3-ligand associated diseases
09/16/2010WO2010103515A2 Compositions and methods for prevention and treatment of neurodegenerative diseases
09/16/2010WO2010103488A1 Dengue virus-like particle and uses thereof
09/16/2010WO2010103289A1 Biological materials and uses thereof
09/16/2010WO2010103284A1 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
09/16/2010WO2010103070A2 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
09/16/2010WO2010103038A1 Interleukin-21 variants having antagonistic binding to the il-21 receptor
09/16/2010WO2010102886A1 Modification of factor viii
09/16/2010WO2010102822A1 Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines
09/16/2010WO2010102380A1 Potent vegf antagonists
09/16/2010WO2010102337A1 Injectable biomaterials
09/16/2010WO2010088463A3 Polypeptides having expansin activity and polynucleotides encoding same
09/16/2010WO2010088411A3 Conformationally dynamic peptides
09/16/2010WO2010085039A3 Noggin-derived peptide and use thereof
09/16/2010WO2010079383A3 Rice brown planthopper resistance gene and applications thereof
09/16/2010WO2010065546A3 MAINTENANCE/EXPANSION OF HSCs
09/16/2010WO2010059689A3 Rsv f vlps and methods of manufacture and use thereof
09/16/2010WO2010057203A3 Hdl particles for delivery of nucleic acids
09/16/2010WO2010054221A3 Treatment of chronic inflammatory respiratory disorders
09/16/2010WO2010053621A3 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof
09/16/2010WO2010047519A3 Heart tissue specific gene mmh1
09/16/2010WO2010039224A3 Respiratory syncytial virus (rsv) sequences for protein expression and vaccines
09/16/2010WO2010021697A3 Antibodies to ccr2
09/16/2010WO2009106999A3 Hollow nanoparticles and uses thereof
09/16/2010WO2009083968A8 Novel protein
09/16/2010WO2005060664A8 Stress tolerant plants and methods thereof
09/16/2010US20100235947 Rice Pollen-Preferential Promoters And Uses Thereof
09/16/2010US20100235944 Grain Quality Through Altered Expression of Seed Proteins
09/16/2010US20100235935 Plasma anti-diabetic nucb2 peptide (pladin) and uses thereof
09/16/2010US20100235934 Hydrocarbon-producing genes and methods of their use
09/16/2010US20100235933 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders
09/16/2010US20100234579 Silver nanoparticle binding agent conjugates based on moieties with triple cyclic disulfide anchoring groups
09/16/2010US20100234569 Aqueous processing of oilseed press cake
09/16/2010US20100234568 Identification of peptide tags for the production of insoluble peptides by sequence scanning
09/16/2010US20100234562 Acute leukemia and lymphoblastic lymphona-specific cd43 epitope and use thereof
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/16/2010US20100234301 Methods and Compositions for the Treatment of Gastrointestinal Disorders
09/16/2010US20100234300 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 2916